옵션 체인은 다양한 행사가격과 만기일에 대한 Incannex Healthcare의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 Incannex Healthcare에 대한 시장 심리를 평가합니다..

Incannex Healthcare (NASDAQ:IXHL) 주식, 옵션 체인

Incannex Healthcare

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Incannex Healthcare Inc

Morgan Stanley analyst Carlos De Alba upgrades MP Materials (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MP#NYSE">MP</a>) from Equal-Weight to Overweight and raises the price target from $23 to $34.

News

Upgrades

Price Target

Analyst Ratings

Morgan Stanley Upgrades MP Materials to Overweight, Raises Price Target to $34

Trading Ideas

Live On CNBC, Josh Brown Hosts Segment Titled "Josh's Best Stock Spotlight: Deere"

Morgan Stanley analyst Joseph Moore upgrades Applied Mat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>) from Underweight to Equal-Weight and lowers the price target from $162 to $158.

AMAT

Morgan Stanley Upgrades Applied Mat to Equal-Weight, Lowers Price Target to $158

Plug Power Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLUG#NASDAQ">PLUG</a>) shares surged 14.4% to 99 cents Friday morning, despite a lack of company-specific news. The move appears partly driven by positive sentiment in the clean energy sector following peer FuelCell Energy's restructuring <a href="https://www.benzinga.com/trading-ideas/movers/25/06/45815607/fuelcell-energy-stock-soars-after-mixed-q2-results-targets-profitability-with-scaled-back-ops-renewed-tech-focus">announcement</a>, and reinforced by Plug's own recent strategic developments.
What To Know: In May, Plug shares gained 4%, supported by <a href="https://www.benzinga.com/news/25/05/45654505/plug-power-stock-is-rising-today-whats-going-on">executive actions</a>, financial updates and operational progress. Notably, the company filed a mixed shelf offering on May 28, enhancing its financial flexibility by enabling the issuance of equity and debt securities as needed. 
While such offerings can raise dilution concerns, they also provide critical funding avenues amid ongoing liquidity pressures.
Earlier in May, Plug <a href="https://www.benzinga.com/news/earnings/25/05/45387898/plug-power-stock-is-tumbling-tuesday-whats-going-on">reported</a> first-quarter revenue of $133.67 million, an 11% year-over-year increase, beating expectations. The surge was driven by a 575% increase in GenEco electrolyzer sales. However, a net loss of 21 cents per share, wider than expected, prompted analyst caution over profitability and cash flow.
Investor confidence was bolstered when CFO Paul Middleton purchased 350,000 shares on May 19, and CEO Andy Marsh pledged to take half his 2025 pay in company stock.
Despite challenges, Plug continues scaling hydrogen production and reaffirms its path to profitability by 2025.
Read Also: <a href="https://www.benzinga.com/trading-ideas/movers/25/06/45815607/fuelcell-energy-stock-soars-after-mixed-q2-results-targets-profitability-with-scaled-back-ops-renewed-tech-focus">FuelCell Energy Stock Soars After Mixed Q2 Results: Targets Profitability With Scaled-Back Ops, Renewed Tech Focus</a>
<h2 class="wp-block-heading">How To Buy PLUG Stock</h2>
By now you're likely curious about how to participate in the market for Plug Power &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, PLUG has a 52-week high of $3.34 and a 52-week low of $0.69.
Image: Shutterstock

PLUG

Plug Power Stock Surges 13%: What's Going On?

Live On CNBC, Kevin Simpson Announces Bought Merck & Company; Sold Salesforce

Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) continues to slide, down over 10% on the week, coinciding with escalating tensions between <a href="https://www.benzinga.com/markets/market-summary/25/06/45809203/investors-pay-the-price-as-musk-trump-war-of-words-escalates-once-allies-now-foes-their-linked-stocks-crypto-and-funds-wipe-out-155-billion-in-a-single-day" title="https://www.benzinga.com/markets/market-summary/25/06/45809203/investors-pay-the-price-as-musk-trump-war-of-words-escalates-once-allies-now-foes-their-linked-stocks-crypto-and-funds-wipe-out-155-billion-in-a-single-day">https://www.benzinga.com/markets/market-summary/25/06/45809203/investors-pay-the-price-as-musk-trump-war-of-words-escalates-once-allies-now-foes-their-linked-stocks-crypto-and-funds-wipe-out-155-billion-in-a-single-day</a>.
What Happened: Prominent crypto analyst Kevin noted in an update in his <a href="https://www.patreon.com/c/KevCapitalTA/posts">exclusive Patreon group</a> that Dogecoin has now retraced to the 0.382 Fibonacci level after breaking below the critical 0.5 support, a move that aligns with oversold daily indicators.
While DOGE and other altcoins show early signs of attempting to reverse bearish momentum on the 4-hour and daily charts, Kevin cautions that significant resistance levels remain overhead.
"I'm fully positioned from lower levels," he noted, adding that he sees no need to add exposure until there&#8217;s clearer direction from Bitcoin, which remains stuck in a choppy, undecided range. 
He urges caution going into Friday, as the current risk-reward setup doesn't justify aggressive moves.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45624852/dogecoins-chart-screams-caution-as-bulls-get-rejected-again">Dogecoin&#8217;s Chart Screams Caution As Bulls Get Rejected Again</a>
Why It Matters: DOGE's sharp decline comes amid the Musk-Trump fallout, sparked by Musk's strong criticism of Trump's "big beautiful bill," which he called a &#8220;debt slavery bill.&#8221; The political spat has rippled into the crypto markets, adding fuel to DOGE's volatility.
Coinbase Assets has <a href="https://x.com/CoinbaseAssets/status/1930360873790435483">launched</a> cbDOGE and cbXRP on Base, with each ERC-20 token backed 1:1 by DOGE and XRP held in Coinbase custody. 
The move expands DOGE&#8217;s utility in DeFi but comes at a time of high market uncertainty.
Coinglass data shows Dogecoin's liquidations in the past 24 hours stood at $27.98 million, with long liquidations of $22.88 million, implying traders' expectations of bullish momentum in the future.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45810884/bitcoin-ethereum-xrp-dogecoin-extend-losses-after-trump-musk-fallout">Bitcoin, Ethereum, XRP, Dogecoin Extend Losses After Trump-Musk Fallout</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$DOGE

Dogecoin Down 10% On The Week: Is The Musk-Trump Spat Bearish For DOGE?

Barrington Research analyst Alexander Paris maintains Perdoceo Education (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRDO#NASDAQ">PRDO</a>) with a Outperform and raises the price target from $38 to $40.

PRDO

Barrington Research Maintains Outperform on Perdoceo Education, Raises Price Target to $40

Live On CNBC, Rob Sechan Announces SoldConocoPhillips; Bought More Jefferies Financial Group

WIIM

FCEL

FuelCell Energy shares are trading higher after the company reported a Q2 sales beat and announced a 22% workforce reduction.

Morgan Stanley analyst Megan Alexander maintains Vail Resorts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTN#NYSE">MTN</a>) with a Equal-Weight and lowers the price target from $152 to $146.

Morgan Stanley Maintains Equal-Weight on Vail Resorts, Lowers Price Target to $146

Live On CNBC, Jenny Harrington Announces Sold Dow, Inc.

Live On CNBC, Jenny Harrington Announces Bought LyondellBasell Industries

Morgan Stanley analyst Josh Baer maintains ServiceTitan (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTAN#NASDAQ">TTAN</a>) with a Equal-Weight and raises the price target from $107 to $109.

TTAN

Morgan Stanley Maintains Equal-Weight on ServiceTitan, Raises Price Target to $109

BSGM

BioSig Technologies shares are trading higher after Ascendiant Capital maintained its Buy rating and raised the price target on the stock from $2.5 to $10.

<a href="https://x.com/BennettJohnT/status/1931025199593365598" title="https://x.com/BennettJohnT/status/1931025199593365598">https://x.com/BennettJohnT/status/1931025199593365598</a>

TSLA

White House Correspondent John T. Bennett Posts On X "There is no effort by Trump admin to terminate some or all of Elon Musk's many government contracts,​ a White House official said. Trump and his aides are focused on passing Republicans' budget reconciliation measure, "and anything else would be a distraction from doing that.""

Morgan Stanley analyst Kimberly Greenberger maintains PVH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PVH#NYSE">PVH</a>) with a Equal-Weight and lowers the price target from $86 to $64.

Morgan Stanley Maintains Equal-Weight on PVH, Lowers Price Target to $64

Macquarie analyst Ross Compton maintains Braze (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRZE#NASDAQ">BRZE</a>) with a Neutral and lowers the price target from $40 to $35.

BRZE

Macquarie Maintains Neutral on Braze, Lowers Price Target to $35

A 26-year-old law student called into &#8220;<a href="https://www.youtube.com/watch?v=KjT_3xyZQs4">The Ramsey Show</a>&#8221; with what started as a financial question and quickly became a conversation about honesty, trust and marriage readiness.
<h2 class="wp-block-heading">Heir To $1 Million, But She Has No Idea</h2>
The caller, Nathaniel, explained that he <a href="https://www.benzinga.com/personal-finance/24/09/40924375/hes-scared-were-going-to-blow-through-it-ramsey-show-caller-says-7-million-inheritance-is-causin">inherited</a> about $1 million a few years ago. The money is held in a trust account that he controls, and it&#8217;s <a href="https://www.benzinga.com/money/best-online-financial-advisors">managed by a financial adviser</a> using a low-risk, principal-protection strategy.
&#8220;I treat it like a sacred gift from God,&#8221; he said. &#8220;I feel like I have a responsibility to be a really excellent steward of it.&#8221;
Don't Miss:
<ul class="wp-block-list">
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a></li>
<li>Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.</li>
</ul>
He said he&#8217;s getting married soon. His fiancée, a pianist, has no assets or liabilities and plans to be a stay-at-home mom. They&#8217;ve been together nearly four years. But she doesn't know about the inheritance—and neither do her parents, who are at the center of Nathaniel's dilemma.
Her parents, retired and living in China, mortgaged their fully paid-off apartment to invest in a risky venture that failed. They are now roughly $25,000 in debt. Nathaniel said they haven't asked him for help, but he's been wondering if it would be wrong not to help them.
&#8220;Would I be a jerk not to?&#8221; he asked. &#8220;Part of me doesn't really feel like using my money, soon to be our money, to help people who, in retirement, mortgaged their only safe asset for leverage in a single risky investment.&#8221;
Trending: <a href="https://www.benzinga.com/money/this-ai-imaging-technology-has-been-used-in-more-than-500-surgeries-now-you-can-be-part-of-the-ai-imaging-revolution">Be part of the next med-tech breakthrough for only $350 — 500+ surgeries already done with nView's AI system.</a>
<h2 class="wp-block-heading">Ramsey: You Can't Marry Someone You&#8217;re Hiding This From</h2>
Dave Ramsey and co-host Jade Warshaw were transparent: the financial question comes second.
&#8220;You don&#8217;t go another day promising to marry somebody and you&#8217;re keeping secrets from them,&#8221; Ramsey said. &#8220;Unhealthy, dude.&#8221;
He urged Nathaniel to have a serious, honest conversation with his fiancée immediately.
&#8220;If you can&#8217;t trust them, you don&#8217;t need to be able to marry them,&#8221; Ramsey said. &#8220;If you have to deceive someone because you&#8217;re worried about their authenticity, we don&#8217;t marry them.&#8221;
Warshaw added that the issue reflects more on Nathaniel than his future in-laws.
&#8220;Honestly, that&#8217;s more on his authenticity than hers,&#8221; she said. &#8220;Nathaniel, you&#8217;re more of the problem here than they are.&#8221;
See Also: Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>.
<h2 class="wp-block-heading">Helping Or Enabling?</h2>
Ramsey acknowledged that $25,000 is a small amount relative to Nathaniel&#8217;s wealth and paying it off would have &#8220;absolutely no impact on your life.&#8221; But he warned against enabling repeated financial mistakes.
&#8220;You don&#8217;t want to do that if they&#8217;re going to turn around and do the same kind of stupid stuff again,&#8221; he said. &#8220;I want to get under the hood and find out what&#8217;s broken. Is this like a pattern? Have we learned our lesson?&#8221;
In the end, Ramsey said the in-laws&#8217; debt is a secondary issue that the couple should discuss after Nathaniel fully discloses his financial situation.
&#8220;Nine out of 10, Nathaniel needs to come clean. One out of 10, pay off the 25K or don&#8217;t,&#8221; Ramsey said.
Read Next: <a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.
Image: Shutterstock

Personal Finance

Ramsey Caller Inherited A Million Dollars And Kept It A Secret. Asks If He'd 'Be A Jerk' Not To Pay Off His Fiancée's Parents' Debt In China

AVGO

Live On CNBC, Stephanie Link Announces Bought More Broadcom

Morgan Stanley analyst Simeon Gutman maintains Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) with a Equal-Weight and lowers the price target from $5 to $4.5.

WOOF

Morgan Stanley Maintains Equal-Weight on Petco Health and Wellness, Lowers Price Target to $4.5

Earnings

Press Releases

Incannex Healthcare Inc. Reports Fiscal Second Quarter 2025 Financial Results and Business Updates

Financing

Incannex Healthcare Inc. Announces Pricing of $12.5 Million Private Placement Priced at the Market Under Nasdaq Rules

Incannex Healthcare Completes Phase 2 Enrollment in RePOSA Phase 2/3 Trial of IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)

Health Care

Incannex Healthcare Inc. Provides Clinical Program Update on IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)

Incannex Healthcare Inc. Reports Fiscal Third Quarter 2025 Financial Results and Business Updates

Incannex Announces Potential Reduction of Up to 50.4% of its Series A Warrants

Incannex Healthcare Inc. Executes Strategic Cancellation of 50.4% of Series A Warrants, Significantly Reducing Potential Dilution

Incannex Healthcare Inc. Enters Agreement to Cancel Remaining Series A Warrants, Eliminating Up to 347.2 Million Shares from Potential Dilution Ahead of IHL-42X Phase 2 Topline Results

Incannex Healthcare Inc. Advances IHL-42X RePOSA Trial to Phase 3 Following FDA Protocol Clearance

Management

Incannex Healthcare Inc. Expands IHL-42X Clinical Advisory Board with Appointments of Four Industry and Academic Leaders to Advance Obstructive Sleep Apnea (OSA) Program

Comments

Incannex Healthcare

Incannex Healthcare (IXHL) 옵션

No option chain data available. Please try again later

뉴스

파트너 / 기고자

벤징가 글로벌